Abstract

The pharmaceutical industry has been constantly pushing the boundaries of science and technology to develop new and innovative treatments for various diseases. With the emergence of new technologies and a deeper understanding of the human body, the industry has made significant progress in recent years, leading to a wave of groundbreaking treatments. One of the key areas of focus for pharmaceutical companies has been the development of gene therapies. Gene therapy involves the introduction of healthy genes into the body to replace or compensate for abnormal or missing genes that cause disease. This has the potential to cure or alleviate a range of genetic disorders, such as sickle cell anemia and cystic fibrosis.